UPMC Department of Cardiothoracic Surgery
Welcome,         Profile    Billing    Logout  
 56 Trials 
75 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Luketich, James D
NCT01345539: Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

Terminated
2
24
US
Stereotactic Radiosurgery (SRS), CyberKnife, Trilogy, True Beam, Chemotherapy
Steven Burton
Oligometastatic Disease
05/22
10/22
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT05591053: Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

Recruiting
N/A
70
US
ActivSight
Activ Surgical, University of Pittsburgh Medical Center, West Penn Allegheny Health System
Esophagus Cancer, Esophageal Cancer, Esophageal Neoplasms, Esophageal Diseases, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagus SCC, Esophagus Tumor, Esophagus Adenocarcinoma, Esophagus Neoplasm
01/25
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Christie, Neil A
NCT01345539: Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

Terminated
2
24
US
Stereotactic Radiosurgery (SRS), CyberKnife, Trilogy, True Beam, Chemotherapy
Steven Burton
Oligometastatic Disease
05/22
10/22
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Landreneau, Rodney J
NCT01345539: Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

Terminated
2
24
US
Stereotactic Radiosurgery (SRS), CyberKnife, Trilogy, True Beam, Chemotherapy
Steven Burton
Oligometastatic Disease
05/22
10/22
Pennathur, Arjun
NCT01345539: Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

Terminated
2
24
US
Stereotactic Radiosurgery (SRS), CyberKnife, Trilogy, True Beam, Chemotherapy
Steven Burton
Oligometastatic Disease
05/22
10/22
NCT01720836: Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Recruiting
1/2
30
US
Vaccine + PolyICLC
Olivera Finn
Non-small Cell Lung Cancer (NSCLC)
10/26
10/31
NCT03300817: MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer

Active, not recruiting
1
50
US
Laboratory Biomarker Analysis, MUC1 Peptide-Poly-ICLC Vaccine
National Cancer Institute (NCI)
Lung Carcinoma
09/21
12/25
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT03802981: A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)

Active, not recruiting
N/A
338
Canada, US
Memorial Sloan Kettering Cancer Center, M.D. Anderson Cancer Center, Brigham and Women's Hospital, Duke University, Mayo Clinic, Université de Montréal, University of Pittsburgh, University of Toronto, Washington University School of Medicine
Multiple Ground Glass Opacities (GGOs)
01/26
01/26
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Schuchert, Matthew
NCT01345539: Radiosurgery for Patients With Oligometastatic Disease at Initial Presentation

Terminated
2
24
US
Stereotactic Radiosurgery (SRS), CyberKnife, Trilogy, True Beam, Chemotherapy
Steven Burton
Oligometastatic Disease
05/22
10/22
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
ALCHEMIST Screening, NCT02194738: Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The Trial)

Recruiting
N/A
8300
US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Carboplatin, Blastocarb, Carboplat, Carboplatin Hexal, Carboplatino, Carboplatinum, Carbosin, Carbosol, Carbotec, CBDCA, Displata, Ercar, JM-8, JM8, Nealorin, Novoplatinum, Paraplatin, Paraplatin AQ, Paraplatine, Platinwas, Ribocarbo, Cisplatin, Abiplatin, Blastolem, Briplatin, CDDP, Cis-diammine-dichloroplatinum, Cis-diamminedichloridoplatinum, Cis-diamminedichloro Platinum (II), Cis-diamminedichloroplatinum, Cis-dichloroammine Platinum (II), Cis-platinous Diamine Dichloride, Cis-platinum, Cis-platinum II, Cis-platinum II Diamine Dichloride, Cismaplat, Cisplatina, Cisplatinum, Cisplatyl, Citoplatino, Citosin, Cysplatyna, DDP, Lederplatin, Metaplatin, Neoplatin, Peyrone's Chloride, Peyrone's Salt, Placis, Plastistil, Platamine, Platiblastin, Platiblastin-S, Platinex, Platinol, Platinol- AQ, Platinol-AQ, Platinol-AQ VHA Plus, Platinoxan, Platinum, Platinum Diamminodichloride, Platiran, Platistin, Platosin, Clinical Observation, observation, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Crizotinib, Alkixen, Crizocent, MET Tyrosine Kinase Inhibitor PF-02341066, PF 02341066, PF-02341066, PF-2341066, PF02341066, Xalkori, Cytology Specimen Collection Procedure, Cytologic Sampling, Echocardiography, EC, Erlotinib, Gemcitabine Hydrochloride, dFdCyd, Difluorodeoxycytidine Hydrochloride, Gemcitabine HCI, Gemzar, LY 188011, LY-188011, LY188011, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo, Paclitaxel, Anzatax, Asotax, Bristaxol, Praxel, Taxol, Taxol Konzentrat, Pembrolizumab, BCD-201, GME 751, GME751, Keytruda, Lambrolizumab, MK 3475, MK-3475, MK3475, Pembrolizumab Biosimilar BCD-201, Pembrolizumab Biosimilar GME751, Pembrolizumab Biosimilar QL2107, Pembrolizumab Biosimilar RPH-075, QL2107, RPH 075, RPH-075, RPH075, SCH 900475, SCH-900475, SCH900475, Pemetrexed, MTA, Multitargeted Antifolate, Pemfexy, Pemetrexed Disodium, Alimta, Almita, LY231514, N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic Acid Disodium Salt, Placebo Administration, Positron Emission Tomography, Medical Imaging, Positron Emission Tomography, PET, PET Scan, Positron emission tomography (procedure), Positron Emission Tomography Scan, Positron-Emission Tomography, proton magnetic resonance spectroscopic imaging, PT
National Cancer Institute (NCI)
Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Cancer AJCC v8
09/26
09/26
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Shende, Manisha
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
Crist, Lawrence
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
Weksler, Benny
STABLE-MATES, NCT02468024: JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer

Recruiting
3
272
Europe, Canada, US, RoW
Lung Surgery, SR, Radiation therapy, SAbR
University of Texas Southwestern Medical Center
Non-Small Cell Lung Cancer
12/28
12/28
NCT04913415: A Study to Evaluate Routine Chest Tube Management After Minimally Invasive Lung Surgery

Active, not recruiting
N/A
160
US
Low Suction Strategy of Chest Tube Management, Standard Suction Strategy of Chest Tube Management
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Lung Cancer
08/24
08/24
NCT03802981: A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)

Active, not recruiting
N/A
338
Canada, US
Memorial Sloan Kettering Cancer Center, M.D. Anderson Cancer Center, Brigham and Women's Hospital, Duke University, Mayo Clinic, Université de Montréal, University of Pittsburgh, University of Toronto, Washington University School of Medicine
Multiple Ground Glass Opacities (GGOs)
01/26
01/26
NCT01817192: Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer

Recruiting
N/A
1050
Europe, US
Adjuvant Chemotherapy, Radiographic surveillance, 14-Gene Prognostic Assay
Razor Genomics, Encore Clinical
Non-Small Cell Lung Cancer
05/27
05/27
Levy, Ryan
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Awais, Omar
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
McGrath, Kevin
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
Gallagher, Angela
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Sarkaria, Inderpal
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT05591053: Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

Recruiting
N/A
70
US
ActivSight
Activ Surgical, University of Pittsburgh Medical Center, West Penn Allegheny Health System
Esophagus Cancer, Esophageal Cancer, Esophageal Neoplasms, Esophageal Diseases, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagus SCC, Esophagus Tumor, Esophagus Adenocarcinoma, Esophagus Neoplasm
01/25
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Dhupar, Rajeev
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Sanchez, Manuel Villa
NCT05026866: A Donanemab (LY3002813) Study in Participants With Preclinical Alzheimer's Disease (TRAILBLAZER-ALZ 3)

Active, not recruiting
3
2196
Japan, US
Donanemab, LY3002813, Placebo
Eli Lilly and Company
Alzheimer Disease
11/27
11/27
Baker, Nicholas
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50
Ward, Julie
NCT03740542: Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Active, not recruiting
N/A
140
US
Esophagectomy, Pyloroplasty
University of Pittsburgh
Esophagectomy
02/23
01/25
NCT05591053: Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans

Recruiting
N/A
70
US
ActivSight
Activ Surgical, University of Pittsburgh Medical Center, West Penn Allegheny Health System
Esophagus Cancer, Esophageal Cancer, Esophageal Neoplasms, Esophageal Diseases, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Esophagus SCC, Esophagus Tumor, Esophagus Adenocarcinoma, Esophagus Neoplasm
01/25
01/25
NCT00280202: Detection of Genetic Markers of Lung Cancer

Recruiting
N/A
6000
US
Biopsy of the major carinal area, Biopsy of abnormal & suspicious areas of the bronchial tree, Evaluation of the tumor for DNA mutations, Bronchoalveolar Lavage (BAL) for cytokine analysis, Correlation of flow cytometric & RT PCR for TNM stage, Analysis of lymph nodes
University of Pittsburgh, National Institutes of Health (NIH)
Lung Cancer
12/50
12/50
NCT00260572: Outcomes After Medical and Surgical Treatment of Gastroesophageal Reflux Disease

Recruiting
N/A
2500
US
Questionnaires to evaluate QOL, Questionnaires to evaluate heartburn and quality of life, Questionnaire to evaluate satisfaction with treatment, Questionnaire to evaluate presence or absence of pain
University of Pittsburgh
Gastroesophageal Reflux Disease
12/50
12/50
NCT00260559: Outcomes After Esophagectomy with a Focus on Minimally Invasive Esophagectomy and Quality of Life

Recruiting
N/A
3500
US
Questionnaires
University of Pittsburgh
Esophagectomy, Esophageal Cancer
12/50
12/50
NCT00260585: Esophageal Cancer Risk Registry

Recruiting
N/A
7000
US
Survey of client health, personal habits, family history, Blood specimen for non-DNA and DNA parts, Biopsy of esophageal/stomach tissue, lymph nodes, tumor, Biopsies, oral (saliva) and/or secretions, washings or mucosal scrapings/brushing from routine clinical surveillance endoscopies
University of Pittsburgh, National Institutes of Health (NIH), National Cancer Institute (NCI)
Esophageal Cancer, Gastroesophageal Reflux Disease (GERD), Esophageal Diseases, Hiatal Hernia, Esophageal Achalasia
12/50
12/50

Download Options